Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Org Chem ; 89(10): 6651-6663, 2024 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-38663026

RESUMO

This article outlines the process development leading to the manufacture of 800 g of BMS-986189, a macrocyclic peptide active pharmaceutical ingredient. Multiple N-methylated unnatural amino acids posed challenges to manufacturing due to the lability of the peptide to cleavage during global side chain deprotection and precipitation steps. These issues were exacerbated upon scale-up, resulting in severe yield loss and necessitating careful impurity identification, understanding the root cause of impurity formation, and process optimization to deliver a scalable synthesis. A systematic study of macrocyclization with its dependence on concentration and pH is presented. In addition, a side chain protected peptide synthesis is discussed where the macrocyclic protected peptide is extremely labile to hydrolysis. A computational study explains the root cause of the increased lability of macrocyclic peptide over linear peptide to hydrolysis. A process solution involving the use of labile protecting groups is discussed. Overall, the article highlights the advancements achieved to enable scalable synthesis of an unusually labile macrocyclic peptide by solid-phase peptide synthesis. The sustainability metric indicates the final preparative chromatography drives a significant fraction of a high process mass intensity (PMI).


Assuntos
Compostos Macrocíclicos , Compostos Macrocíclicos/química , Compostos Macrocíclicos/síntese química , Peptídeos Cíclicos/química , Peptídeos Cíclicos/síntese química , Antígeno B7-H1/antagonistas & inibidores , Antígeno B7-H1/química , Peptídeos/química , Peptídeos/síntese química , Técnicas de Síntese em Fase Sólida , Estrutura Molecular
2.
AAPS PharmSciTech ; 20(5): 184, 2019 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-31062111

RESUMO

Proper risk analysis needs to be in place to understand the susceptibility of protein to unfold and aggregate in the presence of interfacial and/or shear stress. Certain techniques, such as agitation/shaking studies, have been traditionally used to understand the impact of these stresses on the protein physical stability. However, the stresses applied in these systems are convoluted, making it difficult to define the control strategy (i.e., adjustment in process parameters to reduce foaming/bubble formation, change pump type). We have developed two small-scale tools that allow for the isolation of interfacial and shear stress, respectively. These systems, in combination with computational fluid dynamics and numerical approximations, help simulate the normal operating ranges as well as the proven acceptable ranges for different unit operations such as tangential flow filtration (TFF), mixing, and filling.


Assuntos
Produtos Biológicos/química , Química Farmacêutica/instrumentação , Estabilidade de Medicamentos , Processamento de Imagem Assistida por Computador , Tamanho da Partícula , Estabilidade Proteica , Proteínas/química , Estresse Mecânico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA